Phase 1 vs Phase 2 vs Phase 3 Trials: What Each Stage Actually Looks Like

Every Parkinson's clinical trial is tagged with a phase. Phase 1, Phase 2, Phase 3, sometimes Phase 4 or a hybrid like Phase 1 / Phase 2. Here is what each main phase actually looks like in practice for a participating family.

Phase 1: Small, Short, Mostly About Safety

  • Size: 20 to 100 participants.
  • Length: weeks to a few months for the active phase.
  • Visits: more frequent, because researchers watch closely for side effects.
  • Placebo: often none, especially in early Phase 1 dose ranging studies.
  • Where: usually a small number of academic medical centers, often only one or two.

Phase 2: Medium Size, Longer, Starts Measuring Effect

  • Size: a few hundred participants.
  • Length: a few months to about a year, sometimes with an open label extension.
  • Visits: defined schedule, often every few weeks at first and then monthly.
  • Placebo: often placebo controlled. Treatment to placebo ratio is usually weighted toward treatment, commonly 2 to 1.
  • Where: multiple sites, often a mix of academic medical centers and community research clinics.

Phase 3: Large, Long, Designed to Get Approved

  • Size: hundreds to several thousand participants.
  • Length: one to three years or more.
  • Visits: long term schedule, often monthly at first and then quarterly.
  • Placebo: often placebo controlled or controlled against an existing standard treatment.
  • Where: many sites in many countries. Phase 3 is often the easiest phase to find a participating site near you.

A Side by Side Look

  • What is being asked: Phase 1 is "is it safe?" Phase 2 is "does it work?" Phase 3 is "is it better than what we have?"
  • Number of participants: small, medium, large.
  • Total length: weeks to months, months to a year, one to three years or more.
  • Placebo likelihood: often none, common, very common.
  • Number of sites: small, medium, large and often international.

Which Phase Should Your Family Look At

Phase tells you something about the kind of evidence behind a treatment, not whether the trial is right for you. Time commitment, location, and comfort with early stage data all matter.

Browse Phase 1 trials, Phase 2 trials, or Phase 3 trials directly with the phase filter.